STOCK TITAN

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

(Neutral)
Tags

Progyny (Nasdaq: PGNY) released survey results showing strong demand for personalized, human-led guidance in fertility, pregnancy, postpartum, and menopause care.

71% of members reported added stress from their healthcare journey, 43% said stress hurt work performance, and over 70% wanted trusted human support like Progyny Care Advocates (PCAs).

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – PGNY

+0.82%
+0.82% Session close to close

In the May 28 session, PGNY gained 0.82%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights member survey data showing substantial stress in fertility and women’s ...
Analysis

This announcement highlights member survey data showing substantial stress in fertility and women’s health journeys and strong demand for human-led guidance, with multiple metrics above 50% for stress reduction and empowerment from Progyny Care Advocates. It reinforces Progyny’s positioning around personalized support rather than pure digital tools. In context of recent record Q1 2026 revenue of $328.5M, a new share repurchase authorization of $200M, and product expansion, investors may watch how such qualitative outcomes translate into client wins, member growth, and sustained profitability.

Key Figures

Stress from healthcare journey: 71% Work performance impact: 43% Desire for human support: More than 70% +4 more
7 metrics
Stress from healthcare journey 71% Surveyed members reporting added stress to daily lives
Work performance impact 43% Respondents saying stress affected ability to perform effectively at work
Desire for human support More than 70% Respondents wishing every experience included trusted human support like PCAs
Stress reduction with PCA 60% Respondents saying interactions with a PCA helped reduce care-related stress
Significant stress reduction More than 75% Of those helped, saying PCA support significantly reduced stress
Education and empowerment 63% Respondents saying PCA helped them feel more educated and empowered
Better provider communication 54% Respondents saying PCA helped them better communicate and self-advocate

Historical Context

5 past events · Latest: May 26 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
May 26 Share repurchase plan Positive +0.7% Board authorized up to $200M common stock buybacks using available cash.
May 11 Conference appearance Neutral -4.9% Management scheduled to speak at BofA health care conference with webcast.
May 07 Earnings results Positive +23.8% Reported record Q1 2026 revenue, strong EBITDA, net income, and client growth.
Apr 23 Earnings date notice Neutral -1.8% Announced timing and webcast details for Q1 2026 earnings release and call.
Apr 16 Product launch Positive +3.1% Launched Progyny Select fully insured supplemental fertility and women’s health plan.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive corporate actions (earnings beats, product launches, buybacks) have often seen positive follow-through, while neutral events show mixed or negative reactions.

Recent Company History

Over the last few months, Progyny reported record Q1 2026 revenue of $328.5M with strong profitability, which coincided with a +23.8% move, highlighting sensitivity to earnings strength. A new fully insured supplemental plan launch in April 2026 also saw a positive reaction. In contrast, neutral items like conference participation and earnings-date notices drew small negative moves. The recent $200M share repurchase authorization and governance updates via the 2026 Annual Meeting support an active capital and governance strategy, against which this survey-based brand/positioning news fits as supportive but less catalytic.

Key Terms

iui, infertility, postpartum, menopause
4 terms
iui medical
"When I learned my IUI cycle had not been successful, my PCA immediately called..."
Intrauterine insemination (IUI) is a fertility procedure that places prepared sperm directly into the uterus around the time of ovulation to increase the chance of conception, similar to moving seeds closer to soil before watering. Investors watch IUI because its usage, insurance coverage, medical guidelines, and related devices or drugs affect demand and revenue for clinics and healthcare companies, and changes can signal shifts in a fertility market's growth or risks.
infertility medical
"research continues to show that individuals experiencing infertility report levels of anxiety..."
Failure to achieve pregnancy after a year of regular, unprotected attempts (or after six months for some older women), caused by issues in reproductive organs, hormones, sperm, or other health factors. Investors care because it drives demand for treatments, diagnostics, devices and related services—like a persistent household appliance problem that creates ongoing need for repairs and upgrades—so advances, approvals or coverage changes can materially affect companies and markets in health and biotech.
postpartum medical
"Progyny members navigating fertility, pregnancy and postpartum, and menopause..."
The period after childbirth when a mother’s body, mood and health begin to recover and adjust; it commonly covers the first weeks to months following delivery. Investors care because medical care, medications, devices, screening programs and workplace accommodations tied to this recovery can drive demand, regulatory scrutiny and reimbursement decisions—think of it like the market that opens up to support someone recovering from a major life event.
menopause medical
"fertility, pregnancy, postpartum, and menopause care increasingly view personalized..."
Menopause is the natural stage in a person’s life when menstrual periods stop permanently because the ovaries reduce production of hormones like estrogen and progesterone; it is typically diagnosed after 12 consecutive months without a period. Investors care because menopause drives demand for medical treatments, diagnostic services, over‑the‑counter products and workplace accommodations, similar to a market shift when a large customer group changes its needs, affecting revenue and product strategies across health, consumer and employer sectors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- A new survey from Progyny (Nasdaq: PGNY), a global leader in women’s health and family building solutions, found that people navigating fertility, pregnancy, postpartum, and menopause care increasingly view personalized, human-led healthcare guidance as essential to managing stress and navigating a complex healthcare system.

Among surveyed members, 71% said their healthcare journey added stress to their daily lives, with the top sources including the financial impact of healthcare and treatment, healthcare system complexity, and work/life balance challenges. Patients are not just managing healthcare decisions; they are also managing emotional stress, uncertainty, and mental well-being, all while juggling the everyday demands of work and life. In fact, 43% of respondents said that stress impacted their ability to perform effectively at work.

As Mental Health Awareness Month brings increased attention to the connection between healthcare experiences and emotional well-being, Progyny conducted this survey to better understand the value of human support in an increasingly AI-driven and digital healthcare landscape. The findings showed that more than 70% of respondents said they wish every healthcare experience included knowledgeable and trusted human support, like Progyny Care Advocates® (PCAs). The survey comes at a time when research continues to show that individuals experiencing infertility report levels of anxiety and depression comparable to those facing other serious medical conditions, including cancer and heart disease.

“This research reinforces the importance of human connection and shows that technology alone is not enough, especially during deeply personal and emotional healthcare journeys,” said Dr. Janet Choi, Chief Medical Officer, Progyny. “Patients are looking for more than coverage and digital tools; they want empathy, advocacy, reassurance, and trusted guidance throughout the entire experience. While technology can improve access and efficiency, human support remains one of the most essential components of a cohesive care journey.”

Progyny’s human-led, PCA model connects every member with a dedicated expert trained to proactively provide both clinical and emotional support throughout their healthcare journeys. PCAs help members navigate treatment options, understand benefits coverage, access educational resources, and communicate more effectively with providers, while also serving as a trusted bridge between patients and the complex healthcare system. For many members, PCA support becomes an important source of reassurance during some of the most emotional moments of their care experience.

“My PCA became a trusted source of support who truly knew me, my history, and my journey. When I learned my IUI cycle had not been successful, my PCA immediately called to check in on me, listen, offer encouragement, share mental health resources available to me, and discuss options for treatment next steps to help me navigate what can feel like a marathon of a fertility journey. I felt like I was talking to not only an expert, but also a friend. I’m incredibly thankful for her and for Progyny. It takes a very special person to do this work,” said one Progyny member.

Additional findings from the survey include:

  • 60% of respondents said their interactions with a PCA helped reduce stress related to the care they were seeking
  • Among those respondents, more than 75% said the support Progyny’s PCA team provided significantly helped reduce stress
  • 63% said their PCA helped them feel more educated and empowered in their healthcare journey
  • 54% said their PCA helped them better communicate and self-advocate with providers

Survey respondents included Progyny members navigating fertility, pregnancy and postpartum, and menopause and midlife healthcare journeys.

To learn more about Progyny, visit Progyny.com.

About Progyny

Progyny is a global leader in women’s health and family building solutions, trusted by leading employers, health plans, and benefit purchasers worldwide. Through its comprehensive and personalized approach, Progyny supports members across fertility and family building, pregnancy and postpartum, menopause and midlife, and parent and child well-being journeys. Progyny combines differentiated clinical care, integrated pharmacy support through Progyny Rx®, and personalized guidance from Progyny Care Advocates® to deliver improved member experiences and better health outcomes. For more information, visit www.progyny.com.

For Further Information, Please Contact:

Media:
Alexis Ford
media@progyny.com

Investors:
James Hart
investors@progyny.com


FAQ

What did Progyny (Nasdaq: PGNY) find about demand for human guidance in digital healthcare in May 2026?

Progyny found that most surveyed members want human guidance alongside digital healthcare tools. According to Progyny, more than 70% of respondents wished every healthcare experience included knowledgeable, trusted human support, such as Progyny Care Advocates, to help navigate complex, emotionally demanding care journeys.

How does stress from fertility and family building care affect Progyny (PGNY) members at work?

Stress from healthcare journeys can negatively impact work performance for many Progyny members. According to Progyny, 43% of survey respondents said stress from managing fertility, pregnancy, postpartum, or menopause care affected their ability to perform effectively at work while juggling everyday responsibilities.

What impact do Progyny Care Advocates have on member stress levels, according to the 2026 PGNY survey?

Progyny Care Advocates are reported to help reduce member stress during care. According to Progyny, 60% of respondents said PCA interactions reduced stress related to their care, and over 75% of those indicated the PCA team’s support significantly helped lower their stress during treatment journeys.

How do Progyny Care Advocates (PCAs) support PGNY members in their healthcare journeys?

Progyny Care Advocates provide both clinical and emotional support throughout members’ care journeys. According to Progyny, PCAs help navigate treatment options, explain benefits coverage, connect members to educational resources, and improve communication with providers, acting as a trusted bridge to an often complex healthcare system.

What did the Progyny (PGNY) survey reveal about member empowerment and education in healthcare decisions?

Progyny’s survey indicated that PCA support improves member empowerment and education. According to Progyny, 63% of respondents said their Care Advocate helped them feel more educated and empowered, while 54% reported their PCA improved their ability to communicate and self-advocate with healthcare providers.